Joseph Shulman - Feb 9, 2022 Form 3 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role: Chief Technical Officer
Signature: /s/ Hunter Smith, attorney-in-fact for Joseph Shulman
Stock symbol: RYTM
Transactions as of: Feb 9, 2022
Transactions value $: $0
Form type: 3
Date filed: 2/11/2022, 08:30 PM
Next filing: Feb 15, 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	RYTM	Stock Option (Right to Buy)							Feb 9, 2022	Common Stock	85K	$21.38	Direct	F1
holding	RYTM	Stock Option (Right to Buy)							Feb 9, 2022	Common Stock	37.5K	$30.66	Direct	F2
holding	RYTM	Restricted Stock Units							Feb 9, 2022	Common Stock	6.25K		Direct	F3, F4

Showing 1 to 3 of 3 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock options were granted on July 27, 2020. 25% of the shares subject to the option vested and became exercisable on July 27, 2021 and the remaining 75% of the shares subject to the option shall vest and become exercisable in 12 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer thereafter.
F2	The stock options were granted on February 11, 2021. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
F3	The restricted stock units vest as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date.
F4	Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Remarks:

Exhibit List Exhibit 24 - Power of Attorney